Opening of the first 3 Health Points in line with the Business Plan and following the resolutions of the Extraordinary Shareholders’ Meeting
A little more than a month since the press conference of November 22 during which they announced the launch, the innovative SME Health Italy S.p.A, via its subsidiary Health Point S.r.l., has already opened its first three light public health facilities in Italy, the “Health Points”.
The facilities are located in the “Globe” shopping centre of Busnago, a few kilometres from Milan, in the Shopville Gran Reno shopping centre of Casalecchio di Reno, near Bologna, and in Formello, very close to Rome, in the Palasalute where Health Italy S.p.A. is headquartered.
Their launch is fully aligned with the assumptions of the Business Plan approved by the Board of Directors in 28 December 2017, as well as with the decisions of the Extraordinary Assembly of Shareholders that was held on the same day at the offices of Health Italy S.p.A. in Via Santa Cornelia 9, Formello (Rome) and that discussed and deliberated:
- An increase in net share capital in dilutable form, excluding the right of preference, by issuing shares to be released in capital goods according to art. 2441, paragraph 4.
- The issue of a bond convertible into shares for a total maximum amount of Euro 10,000,000.00.
- An increase in net share capital in dilutable form in accordance with art. 2420-bis, with the exclusion of the right of preference in accordance with art. 2441, paragraph 5, destined to the conversion of the convertible bond for a maximum amount of Euro 10,000,000.00 including surcharge.
The resolutions passed by the assembly of Health Italy are part of the company’s new strategic plan and are aimed at providing the company with even more consistent capitalisation as well as adequate financial resources to support the new Industrial Plan for 2018-2020. The objective of the plan is to increase revenue up to 60 million Euro in 2020 with a projected EBITDA of over 20 million Euro.
In particular, the issue of the convertible bond is part of the company’s growth strategy focused on the “Health Point” project and on the development of the Italian research company SBM – Science of Biology in Medicine, 51% of which was acquired by Health Italia last November:
- thanks to the Health Point project, the over 400,000 clients of Health Italia S.p.A. and all citizens who are interested in the project will be able to discover and have access to its health services supported by an intense targeted communication campaign;
- the acquisition of 51% of SBM – Science of Biology in Medicine will allow Health Italia to enter a market that increase by 7.4% in the last twelve months, with the aim of spreading and promoting natural supplements and medical devices, following an innovative approach in terms of “health care before disease cure”.
Health Italia has also the objective to move from the Italian AIM market to the STAR segment of the Italian MTA market of Borsa Italiana, which is dedicated to medium-sized companies with market capitalisation between 40 million and 1 billion Euro.
Roberto Anzanello, President of Health Italia SpA, expressed great satisfaction and commented that “having the same goals and strategic vision between shareholders and management and precise adherence to the plan are decisive values for Health Italia in order to achieve the important objectives of the 2018-2020 Business Plan that will allow us to strengthen our leadership position in the Integrated Healthcare sector, also thanks to all important strategic initiatives that the company has launched”.
